Clinical trial

A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.

NCT01721135

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2010-09-01

PhasePHASE1

Study timeline

Study start (unknown)2010-09-01Date precision: month

Registry last updated2013-08-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

GSK2190915 100mgDRUG

GSK2190915 200mgDRUG

moxifloxacin 400mgDRUG

moxifloxacin placeboDRUG

GSK2190915 placeboDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01721135 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.